Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations. 
X
Please Wait
Applying Filters...
01 Dr.Reddy's Laboratories Limited (1)
02 SUN PHARMACEUTICAL INDUSTRIES, INC. (1)
03 Aurobindo Pharma Limited (1)
04 BLUEBAY SHANDONG CO.,LTD (1)
05 DARMERICA, LLC (1)
06 F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (2)
07 Formosa Laboratories, Inc. (1)
08 Hetero Labs Limited (1)
09 Hubei Biocause Heilen Pharmaceutical Co., Ltd (1)
10 LAURUS LABS LIMITED (1)
11 Laurus Labs Limited (1)
12 MSN Laboratories Private Limited (2)
13 Natco Pharma Limited (1)
14 Pliva Croatia Ltd (1)
15 SHILPA PHARMA LIFESCIENCES LIMITED (2)
16 Sterling Pharma Solutions Limited (1)
17 Valary Lab Private Limited (1)
18 zhejiang jiuzhou pharmaceutical Co., Ltd. (1)
01 IMATINIB (1)
02 IMATINIB MESILATE (1)
03 IMATINIB MESYLATE (1)
04 Imatinib (2)
05 Imatinib Mesylate (12)
06 Imatinib Mesylate (IMA) (1)
07 Imatinib Mesylate (IMN) (1)
08 Imatinib mesylate (2)
01 China (3)
02 Croatia (1)
03 India (11)
04 Italy (2)
05 Taiwan (1)
06 U.S.A (1)
07 United Kingdom (1)
08 Blank (1)
82
PharmaCompass offers a list of Imatinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imatinib Mesylate manufacturer or Imatinib Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imatinib Mesylate manufacturer or Imatinib Mesylate supplier.
PharmaCompass also assists you with knowing the Imatinib Mesylate API Price utilized in the formulation of products. Imatinib Mesylate API Price is not always fixed or binding as the Imatinib Mesylate Price is obtained through a variety of data sources. The Imatinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imatinib Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib Mesylate, including repackagers and relabelers. The FDA regulates Imatinib Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imatinib Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imatinib Mesylate supplier is an individual or a company that provides Imatinib Mesylate active pharmaceutical ingredient (API) or Imatinib Mesylate finished formulations upon request. The Imatinib Mesylate suppliers may include Imatinib Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Imatinib Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imatinib Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imatinib Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imatinib Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imatinib Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imatinib Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imatinib Mesylate suppliers with NDC on PharmaCompass.
We have 16 companies offering Imatinib Mesylate
Get in contact with the supplier of your choice:
